Can a common steroid tame Tick-Borne brain infection?
NCT ID NCT07584525
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the steroid dexamethasone can reduce brain damage in adults hospitalized with tick-borne encephalitis. Researchers will compare disability outcomes in 200 patients who receive either dexamethasone or a placebo. The goal is to see if this treatment lowers the risk of long-term neurological problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TICK-BORNE ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Ljubljana
RECRUITINGLjubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.